newsfilter
← Latest News
Bloomberg·

Small-Cap Biotech Surges Almost 350% on Cancer-Drug Trial Data

Small-cap drug developer Five Prime Therapeutics Inc. is on track to post one of this year’s biggest daily stock moves after reporting promising data from a mid-stage cancer study.